Your browser doesn't support javascript.
loading
Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses.
Quandt, Jasmin; Schlude, Christoph; Bartoschek, Michael; Will, Rainer; Cid-Arregui, Angel; Schölch, Sebastian; Reissfelder, Christoph; Weitz, Jürgen; Schneider, Martin; Wiemann, Stefan; Momburg, Frank; Beckhove, Philipp.
Afiliação
  • Quandt J; Department of Translational Immunology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Schlude C; Knapp Research Center, Section of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Bartoschek M; Department of Translational Immunology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Will R; Department of Translational Immunology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Cid-Arregui A; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Schölch S; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Reissfelder C; Department of Translational Immunology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Weitz J; Targeted Tumor Vaccines Group, Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schneider M; Department of Visceral Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Wiemann S; Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Momburg F; Department of Visceral Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Beckhove P; Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Oncoimmunology ; 7(12): e1500671, 2018.
Article em En | MEDLINE | ID: mdl-30524892
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article